Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-Widefield Fluorescein Angiography Findings in Patients With Retinitis Pigmentosa.

Journal of vitreoretinal diseases·2026
Same author

Long-Term Mechanical Complications After Lumbar Fusion in Patients Receiving Tirzepatide vs Other GLP-1 Receptor Agonists.

Spine·2026
Same author

Incidence and Predictors of IOP-Lowering Treatment Following Detection of Referable Glaucoma in a Teleretinal Screening Program.

medRxiv : the preprint server for health sciences·2026
Same author

Risk-Stratified Monitoring of Open Angle Glaucoma Suspects Based on Diagnostic Conversion Risk.

American journal of ophthalmology·2026
Same author

Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study.

Ophthalmology·2026
Same author

Association of Immune Checkpoint Inhibitors With Otologic Symptoms: A Propensity Score-Matched Study.

The Laryngoscope·2026

Related Experiment Videos

Comparative risk of glaucoma surgery in uveitis-associated versus primary open-angle glaucoma: a multicentre database

Alexander T Hong1, Jason S Chwa1, Albert Yang1

  • 1Department of Ophthalmology, USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|June 18, 2026
PubMed
Summary

Patients with uveitis-associated glaucoma face a higher risk of bleb-forming surgeries, particularly aqueous shunts, compared to primary open-angle glaucoma patients. Early identification and tailored management are crucial for this high-risk group.

Related Experiment Videos

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Inflammatory Eye Diseases

Background:

  • Glaucoma management in patients with uveitis presents unique challenges.
  • Understanding treatment patterns is crucial for optimizing patient outcomes.
  • Primary open-angle glaucoma (POAG) serves as a standard comparison group.

Purpose of the Study:

  • To compare treatment strategies for newly diagnosed glaucoma in patients with and without uveitis.
  • To identify predictors of surgical intervention in uveitis-associated glaucoma.

Main Methods:

  • Retrospective cohort study utilizing a multicenter electronic health record network.
  • Adults aged 40+ with glaucoma were classified based on uveitis history.
  • Propensity score matching was used to compare uveitis-associated glaucoma cohorts with POAG controls.
  • Surgical interventions (bleb-forming and non-bleb-forming) and IOP-lowering drops were assessed over 10 years.

Main Results:

  • Uveitis-associated glaucoma demonstrated a significantly higher risk of bleb-forming surgeries (HR: 1.75) compared to POAG.
  • Aqueous shunt procedures were notably more frequent in the uveitis group (HR: 2.95).
  • Predictors for bleb-forming surgery included male sex, Hispanic ethnicity, anterior uveitis, nicotine dependence, higher BMI, and immunomodulatory therapy.

Conclusions:

  • Uveitis-associated glaucoma necessitates a higher likelihood of bleb-forming surgical interventions, especially aqueous shunts.
  • This finding underscores the importance of early diagnosis and individualized treatment plans for uveitis patients.
  • The study identifies key predictors that may guide surgical decision-making in this population.